Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

BP3260a

Phospho-STAT3(S727) Antibody Blocking peptide

Abcepta

DETAILS

  • Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
  • Gene Id: 6774
  • Category: Peptides; Blocking Peptides
  • Subtitle: Synthetic peptide
  • Gene Name: STAT3
  • Other Names: Signal transducer and activator of transcription 3, Acute-phase response factor, STAT3, APRF
  • Availability: 2 weeks
  • Bio Background: The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated through phosphorylation in response to various cytokines and growth factors including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2. This protein mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis. The small GTPase Rac1 has been shown to bind and regulate the activity of this protein. PIAS3 protein is a specific inhibitor of this protein. Three alternatively spliced transcript variants encoding distinct isoforms have been described. Transcript Variant: This variant (1) represents a longer transcript, and encodes a longer isoform (1).
  • Bio References: Schick, N., et al., J. Biol. Chem. 279(37):38787-38796 (2004).Wang, H., et al., Lab. Invest. 84(8):941-951 (2004).Kato, T., et al., J. Biol. Chem. 279(30):31076-31080 (2004).Ivanova, A.V., et al., J. Mol. Biol. 340(4):641-653 (2004).Park, J., et al., Biochem. Biophys. Res. Commun. 320(1):279-285 (2004).
  • Primary Accession: P40763
  • Targetspecificity: The synthetic peptide sequence used to generate the antibody AP3260a was selected from the 721-733 region of human Phospho-STAT3-Y727. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.